Loading clinical trials...
Loading clinical trials...
A Trial of Tandem Autologous Stem Cell Transplants +/- Post Second Autologous Transplant Maintenance Therapy vs Single Autologous Stem Cell Transplant Followed by Matched Sibling Non-myeloablative Allogeneic Stem Cell Transplant for Patients With Multiple Myeloma (BMT CTN #0102)
Conditions
Interventions
One Autologous Transplant
Non-Myeloablative Allogeneic Transplant
+4 more
Locations
36
United States
University of Alabama at Birmingham
Birmingham, Alabama, United States
City of Hope Samaritan
Phoenix, Arizona, United States
City of Hope National Medical Center
Duarte, California, United States
Scripps Clinic/Green Hospital
La Jolla, California, United States
UCSD Medical Center
La Jolla, California, United States
Stanford Hospital and Clinics
Stanford, California, United States
Start Date
December 1, 2003
Primary Completion Date
June 1, 2012
Completion Date
March 1, 2013
Last Updated
November 1, 2021
NCT07249528
NCT06215118
NCT06679101
NCT05969860
NCT06870760
NCT06383143
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions